News

News

April 10, 2014 — Patients presenting to the emergency department with an undetectable level of the blood biomarker high-sensitivity cardiac troponin T, and whose ECGs (electrocardiograms) show no...

April 10, 2014 — The largest single-center study of patients implanted with a total artificial heart found the device may help patients in severe heart failure survive until they can receive a...

Cardiac Ultrasound Blood Clots Heart Brain ACC.14

A study with a new ultrasonic scanning technique shows that scanning of the carotid arteries can reveal who is at high risk of being hit by a blood clot. 

LipoScience Inc. announced data showing that patients managed to a target LDL particle (LDL-P) number, as measured by LipoScience's NMR LipoProfile test, achieved a 22 to 25 percent greater...

GE Healthcare Q.Clear Technology PET/CT Systems Nuclear Imaging

GE Healthcare received U.S. Food and Drug Administration (FDA) 510(k) clearance of its Q.Clear technology, which is designed to provide up to two times improvement in both quantitative accuracy...

Cardinal Health AccessClosure Acquisition Vascular Closure Devices Cath Lab

Cardinal Health announced an agreement to acquire privately held AccessClosure Inc. for $320 million. 

SCAI ACC.14 Choosing Wisely Campaign Tests Treatments to Avoid Cath Lab

The Society for Cardiovascular Angiography & Interventions (SCAI) issued a list of five specific, evidence-based recommendations that should be avoided in the care of patients who have, or are...

Philips CT, cardiac CTA, calcium scoring, ACC.14

Coronary artery calcium scoring, a test that measures the amount and pattern of calcium that has accumulated in a patient’s coronary arteries, appears to provide an early indication of a person’s...

Philips Healthcare presented new imaging and informatics solutions at the American College of Cardiology Conference (ACC) Annual Meeting. 

GE Healthcare showcased a new suite of connected cardiovascular technologies, including several for advanced imaging and new software capabilities, at ACC 2014. New innovations included advances...

ICD, MADIT-CRT trial, long-term followup, ACC.14

Patients in mild heart failure who receive a cardiac resynchronization therapy defibrillator (CRT-D) device may live longer than those implanted with a traditional implantable...

I had become accustomed to making the necessary tradeoffs when choosing the appropriate defibrillator for my patients and until recently thought that these choices were ones that I would always...

Merge, CVIS, cardiac PACS

Patients do not have to be the only beneficiaries of technological innovation. Indeed, many technological hardware and software solutions are emerging to help cardiac care providers negotiate...

Congress recently passed the Protecting Access to Medicare Act of 2014, which requires use of appropriate use criteria (AUC) and clinical decision support (CDS) software to get Medicare...

In a comparison of two blood-thinning medications, heparin was associated with significantly fewer major cardiovascular events at 28 days than bivalirudin in patients receiving primary...

Epsilon Imaging EchoInsight Cardio Oncology Echo Cardiac Ultrasound

Epsilon Imaging Inc. has expanded its EchoInsight automated measurement suite for improved analysis and interpretation in echo.

April 7, 2014 — A first-ever randomized head-to-head comparison of two devices commonly used to treat aortic stenosis finds balloon-expandable transcatheter valves (such as the Edwards Sapien)...

April 7, 2014 — Strategies aimed at reducing the number of patients with heart failure and other cardiovascular conditions who find themselves back in the hospital after discharge were identified...

Medtronic, SYMPLICITY, SYMPLICITY HTN-3 trial, renal denervation, ACC.14

A major disappointment earlier this year was the announcement by Medtronic that its renal denervation system failed to meet its primary endpoint for efficacy in the U.S. SYMPLICITY HTN-3 trial....

Iodixanol Iopamidol Contrast Media Peripheral Arteriography ACC.14 Clinical Stud

GE Healthcare announced results from a new clinical study, which showed that patients receiving iodixanol (Visipaque) 320mg I/ml reported less discomfort, characterized by heat or cold sensation...